Bone Therapeutics SA (BOTHE):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Bone Therapeutics SA (BOTHE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8198
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. The company offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for the treatment of osteonecrosis and non-union fractures; and ALLOB, an allogeneic osteoblastic cell therapy product, for delayed-union fractures, spinal fusion procedures, and frevision spinal fusion. Bone Therapeutics conducts preclinical research on next generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications. The company conducts clinical studies for treatment of delayed-union fractures and spinal fusion. Bone Therapeutics is headquartered in Gosselies, Belgium.

Bone Therapeutics SA (BOTHE) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Bone Therapeutics SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Bone Therapeutics SA, Medical Devices Deals, 2012 to YTD 2018 10
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Bone Therapeutics Raises US$8 Million In Series D Financing Round 12
Partnerships 13
Bone Therapeutics to Enter into Agreement with Cellthera Pharm 13
Bone Therapeutics Extends Agreement with Kasios 14
Licensing Agreements 15
Asahi Kasei Enters into Licensing Agreement with Bone Therapeutics 15
Bone Therapeutics Enters into Licensing Agreement with Enrico Bastianelli 16
Enrico Bastianelli Enters into Licensing Agreement with Bone Therapeutics 17
Bone Therapeutics Enters into Licensing Agreement with Enrico Bastianelli for BONE-011 18
Equity Offering 19
Bone Therapeutics Withdraws Private Placement of Shares 19
Bone Therapeutics Raises USD38 Million in IPO 21
Debt Offering 23
Bone Therapeutics Raises USD24.1 Million in Private Placement of Bonds 23
Bone Therapeutics SA – Key Competitors 24
Bone Therapeutics SA – Key Employees 25
Bone Therapeutics SA – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Financial Announcements 27
Aug 30, 2018: Bone Therapeutics announces H1 results for 2018 27
Apr 25, 2018: Bone Therapeutics Announces Full Year 2017 Financial Results 28
Nov 09, 2017: Bone Therapeutics: Business Update for Third Quarter 2017 29
Aug 31, 2017: Bone Therapeutics Announces H1 Results for 2017 30
May 11, 2017: Bone Therapeutics Business Update for First Quarter 2017 32
Mar 16, 2017: Bone Therapeutics Reports Full Year 2016 Results 33
Jan 17, 2017: Bone Therapeutics Provides Business Update for Q4 2016 34
Corporate Communications 36
Jun 14, 2018: Bone Therapeutics announces results of Annual General Meeting 36
Apr 26, 2018: Bone Therapeutics Appoints Claudia D’Augusta As Non-Executive Director 37
Feb 20, 2018: Bone Therapeutics strengthens Board with the appointment of Jean Stephenne as Chairman 38
Aug 31, 2017: Bone Therapeutics Appoints Jean-Luc Vandebroek as Chief Financial Officer 39
Jul 03, 2017: Bone Therapeutics Strengthens Board of Directors 40
May 29, 2017: Bone Therapeutics: Strengthens Board with the appointments of Steve Swinson and Damian Marron as Non-Executive Directors 42
Mar 06, 2017: Bone Therapeutics Strengthens Clinical Development Leadership with Appointment of Dr. Miguel Forte as Chief Medical Officer 43
Other Significant Developments 44
Jan 23, 2018: Bone Therapeutics provides business outlook and announces its financial calendar for 2018 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Bone Therapeutics SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Bone Therapeutics SA, Deals By Therapy Area, 2012 to YTD 2018 9
Bone Therapeutics SA, Medical Devices Deals, 2012 to YTD 2018 10
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Bone Therapeutics Raises US$8 Million In Series D Financing Round 12
Bone Therapeutics to Enter into Agreement with Cellthera Pharm 13
Bone Therapeutics Extends Agreement with Kasios 14
Asahi Kasei Enters into Licensing Agreement with Bone Therapeutics 15
Bone Therapeutics Enters into Licensing Agreement with Enrico Bastianelli 16
Enrico Bastianelli Enters into Licensing Agreement with Bone Therapeutics 17
Bone Therapeutics Enters into Licensing Agreement with Enrico Bastianelli for BONE-011 18
Bone Therapeutics Withdraws Private Placement of Shares 19
Bone Therapeutics Raises USD38 Million in IPO 21
Bone Therapeutics Raises USD24.1 Million in Private Placement of Bonds 23
Bone Therapeutics SA, Key Competitors 24
Bone Therapeutics SA, Key Employees 25
Bone Therapeutics SA, Subsidiaries 26

List of Figures
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Bone Therapeutics SA, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Bone Therapeutics SA (BOTHE):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tesla, Inc.:企業の戦略・SWOT・財務分析
    Tesla, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tesla, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Indutrade AB (INDT):企業の財務・戦略的SWOT分析
    Summary Indutrade AB (Indutrade) is an industrial goods company that develops and sells high-tech products and solutions. It carries out acquisition of technology companies. The company acquired companies that manufacture springs, press work, valve channels, piston rings, pipes and pipe systems, ind …
  • MedicPen AB (MPEN):医療機器:M&Aディール及び事業提携情報
    Summary MedicPen AB (MedicPen) is a drug development company that manufactures, develops, and markets patented products. The company’s products include Medimi Pro and Medimi Smart. It also provides Medimi – MedicPen’s system for medication assistance. MedicPen offers automatic filling units for home …
  • Implants International Ltd:企業の製品パイプライン分析
    Summary Implants International Ltd (Implants International) is a medical device company that manufactures, designs, and develops orthopedic implants, bio-engineering, and other products for the healthcare sector. The company’s products include revision systems, hip stems, hip stem ancillaries, aceta …
  • Halliburton Co (HAL)-石油・ガス分野:企業M&A・提携分析
    Summary Halliburton Company (Halliburton) is an oilfield services company. The company serves the upstream oil and gas industry throughout the lifecycle of the reservoir, from identifying hydrocarbons and managing geological data, to drilling and formation evaluation, well construction and completio …
  • President Energy PLC (PPC):石油・ガス:M&Aディール及び事業提携情報
    Summary President Energy PLC (President) is an independent oil and gas exploration and production company. It focuses mainly on Argentina and Paraguay in South America. The company has a diverse portfolio of operated onshore producing and exploration assets. Its major assets include working interest …
  • Abu Dhabi Investment Authority:電力:M&Aディール及び事業提携情報
    Summary Abu Dhabi Investment Authority (ADIA) is a sovereign wealth fund owned and managed by Emirate of Abu Dhabi. It invests directly in global financial markets along with trusted partner’s selected external managers. The company’s investment portfolio includes developed equities, small cap equit …
  • Protonex Technology Corporation:電力:M&Aディール及び事業提携情報
    Summary Protonex Technology Corporation (Protonex) is a fuel cell company, which carries out research, development and production of a wide range of power solutions. It principally offers advanced fuel cell power solutions for portable, remote and mobile applications. The company produces these prod …
  • New York Power Authority:電力:M&Aディール及び事業提携情報
    Summary New York Power Authority (NYPA) is a state-owned power organization. It generates electricity, and transmits and sells that on wholesale basis. The authority produces the electricity using hydro, gas, and oil sources. Through long-term electricity supply agreement with Astoria Energy II LLC, …
  • Accuray Inc (ARAY):製品パイプライン分析
    Summary Accuray Inc (Accuray) carries out the development, manufacture and sale of personalized treatment solutions for radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, and adaptive radiation therapy. The company’s major produc …
  • China Tontine Wines Group Limited:企業の戦略・SWOT・財務情報
    China Tontine Wines Group Limited - Strategy, SWOT and Corporate Finance Report Summary China Tontine Wines Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • IDEXX Laboratories, Inc.:企業の戦略・SWOT・財務情報
    IDEXX Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report Summary IDEXX Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • InSightec Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Insightec Ltd (InSightec), a subsidiary of Elbit Imaging Ltd, is a medical device company that develops and markets magnetic resonance imaging ultrasound based medical devices. The company offers products through divisions such as neurosurgery, urology, oncology and womens’ health. Its servi …
  • New Hope Corp Ltd:企業の戦略・SWOT・財務情報
    New Hope Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary New Hope Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Lockheed Martin Corporation:戦略・SWOT・企業財務分析
    Lockheed Martin Corporation - Strategy, SWOT and Corporate Finance Report Summary Lockheed Martin Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Brazos Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Brazos Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Yaskawa Electric Corp
    Yaskawa Electric Corp - Strategy, SWOT and Corporate Finance Report Summary Yaskawa Electric Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sucrerie Couplet SA:企業の戦略・SWOT・財務情報
    Sucrerie Couplet SA - Strategy, SWOT and Corporate Finance Report Summary Sucrerie Couplet SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Arch Capital Group Ltd.:企業の戦略・SWOT・財務情報
    Arch Capital Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Arch Capital Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Battelle Memorial Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Battelle Memorial Institute (Battelle) is a nonprofit research and development (R&D) organization. It carries out discovery, design, development, and manufacture of products, and renders its services to government and commercial customers. The institute manages national laboratories and main …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆